VOYAGER OTW Coronary Dilatation Catheter

Features and Benefits

Excellent Track with Transitionless Shaft Technology

• Transitionless shaft for uniform push transmission and excellent track
• Variable support along the length of the catheter for excellent push
• Tapered tri-layer inner member is engineered for collapse resistance 

view larger image

Superb Cross with Tapered Tip Design

• Tapered tip with .017" tip entry profile designed to cross tight lesions
• Improved tip-to-wire conformability¹ for confident track and cross
• Flexible yet durable for tough lesions 

view larger image

Precise Dilatation with Proven Balloon Performance

• Short tapers allow for precise dilatation
• Low .024" crossing profile² with LOFOLD Balloon Technology for excellent cross and recross
• XCELON S Balloon Material achieves superb flexibility

view larger image

1. As compared to OPENSAIL Coronary Dilatation Catheter.
2. 3.0 x 20 mm. Tests performed by and data on file at Abbott Vascular.

Specifications

VOYAGER OTW Dilatation Catheter Part Numbers 82.9 KB

Indications and Important Safety Information

The VOYAGER OTW Coronary Dilatation Catheter

Indications, Contraindications, Warnings, Precautions, Adverse Events

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

INDICATIONS

The VOYAGER OTW Coronary Dilatation Catheter is indicated for:

a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.

b) balloon dilatation of a coronary artery occlusion for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction.

c) balloon dilatation of a stent after implantation.

CONTRAINDICATIONS

The VOYAGER OTW Coronary Dilatation Catheter is not intended to be used:

• in an unprotected left main coronary artery;

• to treat coronary artery spasm in the absence of a significant stenosis.

WARNINGS

This device is intended for single-use only; do not reuse. Do not resterilize, as this can compromise device performance and increase the risk of cross contamination due to inappropriate reprocessing.

PTCA (percutaneous transluminal coronary angioplasty) should only be performed at hospitals where emergency coronary artery bypass graft surgery can be quickly performed in the event of a potentially injurious or life-threatening complication.

PTCA in patients who are not acceptable candidates for coronary artery bypass graft surgery requires careful consideration, including possible hemodynamic support during PTCA, as treatment of this patient population carries special risk.

Use only the recommended balloon inflation medium. Never use air or any gaseous medium to inflate the balloon.

Balloon pressure should not exceed the rated burst pressure (RBP). The RBP is based on results of in vitro testing. At least 99.9% of the balloons (with a 95% confidence) will not burst at or below their RBP. To prevent over-pressurization, use a pressure-monitoring device.

To reduce the potential for vessel damage, the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the stenosis.

When the catheter is exposed to the vascular system, it should be manipulated while under high quality fluoroscopic observation. Do not advance or retract the catheter unless the balloon is fully deflated under vacuum and no resistance is felt. If there is resistance, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.

Do not use, or attempt to straighten, a catheter if the shaft has become bent or kinked; this may result in the shaft breaking. Instead, prepare a new catheter.

Treatment of moderately or heavily calcified lesions is considered to be moderate risk, with an expected success rate of 60 - 85% and increases the risk of acute closure, vessel trauma, balloon burst, balloon entrapment and associated complications. If resistance is felt, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.

In the event of catheter damage / separation, recovery of any portion should be performed based on physician determination of individual patient condition and appropriate retrieval protocol.

The VOYAGER OTW Coronary Dilatation Catheter was bench tested with the MULTI-LINK: PIXEL, PENTA, and ZETA Coronary Stent Systems. All stents should be deployed in accordance with the manufacturer's indications and instructions for use.

PRECAUTIONS

Note the “Use By” date specified on the package.

Inspect all product prior to use. Do not use if the package is open or damaged, or if product is damaged.

Prior to angioplasty, the dilatation catheter should be examined to verify functionality and ensure that its size is suitable for the specific procedure for which it is to be used.

During the procedure, provide appropriate anti-coagulant and coronary vasodilator therapy to the patient as needed. Anticoagulant therapy should be continued for a period of time as determined by the physician after the procedure.

If the surface of the dilatation catheter becomes dry, wetting with heparinized normal saline will reactivate the coating.

Do not reinsert the dilatation catheter into the coil dispenser after procedural use.

This device should be used only by physicians experienced in angiography and percutaneous transluminal coronary angioplasty (PTCA) and / or percutaneous transluminal angioplasty (PTA).

ADVERSE EVENTS

Possible adverse effects include, but are not limited to, the following:

• Acute myocardial infarction

• Arrhythmias, including ventricular fibrillation

• Arteriovenous fistula

• Coronary artery spasm

• Coronary vessel dissection, perforation, rupture or injury

• Death

• Drug reactions, allergic reaction to contrast medium

• Embolism

• Hemorrhage or hematoma

• Hypo / hypertension

• Infection

• Restenosis of the dilated vessel

• Total occlusion of the coronary artery or bypass graft

• Unstable angina

Printer Friendly